Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

496 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Baseline prostate-specific antigen testing at a young age.
Loeb S, Carter HB, Catalona WJ, Moul JW, Schroder FH. Loeb S, et al. Eur Urol. 2012 Jan;61(1):1-7. doi: 10.1016/j.eururo.2011.07.067. Epub 2011 Aug 10. Eur Urol. 2012. PMID: 21862205 Review.
The PSA era is not over for prostate cancer.
Catalona WJ, Loeb S. Catalona WJ, et al. Eur Urol. 2005 Oct;48(4):541-5. doi: 10.1016/j.eururo.2005.07.014. Eur Urol. 2005. PMID: 16139417 Review. No abstract available.
Use of 2.6 ng/ml prostate specific antigen prompt for biopsy in men older than 60 years.
Nadler RB, Loeb S, Roehl KA, Antenor JA, Eggener S, Catalona WJ. Nadler RB, et al. J Urol. 2005 Dec;174(6):2154-7, discussion 2157. doi: 10.1097/01.ju.0000181213.07447.8f. J Urol. 2005. PMID: 16280754
Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.
Loeb S, Roehl KA, Antenor JA, Catalona WJ, Suarez BK, Nadler RB. Loeb S, et al. Urology. 2006 Feb;67(2):316-20. doi: 10.1016/j.urology.2005.08.040. Epub 2006 Jan 25. Urology. 2006. PMID: 16442597
A young man's baseline PSA value was a stronger predictor of CaP than family history, race, or suspicious digital rectal examination findings. ...
A young man's baseline PSA value was a stronger predictor of CaP than family history, race, or suspicious digital rectal examination …
Viewpoint: expanding prostate cancer screening.
Catalona WJ, Loeb S, Han M. Catalona WJ, et al. Ann Intern Med. 2006 Mar 21;144(6):441-3. doi: 10.7326/0003-4819-144-6-200603210-00012. Ann Intern Med. 2006. PMID: 16549857
Making prostate-specific antigen testing more effective.
Catalona WJ, Loeb S. Catalona WJ, et al. Urol Oncol. 2006 May-Jun;24(3):177-9. doi: 10.1016/j.urolonc.2005.09.001. Urol Oncol. 2006. PMID: 16678045 No abstract available.
Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression.
Loeb S, Roehl KA, Yu X, Antenor JA, Han M, Gashti SN, Yang XJ, Catalona WJ. Loeb S, et al. Urology. 2006 Jul;68(1):99-103. doi: 10.1016/j.urology.2006.02.004. Epub 2006 Jun 27. Urology. 2006. PMID: 16806410
Use of BioGlue in laparoscopic partial nephrectomy.
Nadler RB, Loeb S, Rubenstein RA, Vardi IY. Nadler RB, et al. Urology. 2006 Aug;68(2):416-8. doi: 10.1016/j.urology.2006.02.038. Urology. 2006. PMID: 16904466
496 results
Jump to page
Feedback